HealthTab™ to Integrate CONTOUR®NEXT Family of Blood Glucose Meters to Offer Deeper Diabetes Patient Insights

VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce its agreement with Ascensia Diabetes Care, a global diabetes care company, to integrate their blood glucose monitoring (BGM) systems, marketed as CONTOUR®NEXT GEN and CONTOUR®NEXT ONE, with Avricore’s pharmacy-based point-of-care testing (POCT) platform, HealthTab. Ascensia Diabetes Care is a subsidiary of PHC Holdings Corporatio

Related Keywords

Vancouver ,British Columbia ,Canada ,United Kingdom ,United States ,British ,Canadians ,Americans ,Hector Bremner ,Annika Pawaroo ,Avricore Health ,Avricore Health Inc ,Holdings Corporation ,Ascensia Diabetes Care Canada Inc ,Health Inc ,Ascensia Diabetes Care ,Region Americas ,Ascensia Diabetes ,Diabetes Care ,Continuous Glucose Monitoring Systems ,Diabetes Care Canada ,Lipid Profile ,Care Testing Market ,Healthtab ,Blood Glucose Monitoring ,Diabetes Management ,Ascensia ,Pharmacists ,Diabetes ,Health Care Provider ,